Positive results today from combination agent animal experiments carried out at a prominent American cancer research facility were announced. The results provide strong supportive evidence for the continued evaluation of COTI-2 in combination with conventional single agent therapy for the treatment of ovarian cancer:

Link:http://criticaloutcome.com/090702_COTI_Ovarian.pdf
Source:Critical Outcome